Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation.

Uffing A, Hidalgo LG, McMullan C, Perry J, Milford EL, Murakami N, Yeung MY, Guleria I, Wood IG, Akalin E, Azzi J, Chandraker AK, Riella LV.

Transplant Direct. 2019 Apr 15;5(5):e446. doi: 10.1097/TXD.0000000000000893. eCollection 2019 May.

2.

Minimal data reporting standards for serological testing for histocompatibility.

Valenzuela NM, Askar M, Heidt S, Jindra P, Madbouly A, Pinelli D, Jackson A, Hidalgo LG.

Hum Immunol. 2018 Dec;79(12):865-868. doi: 10.1016/j.humimm.2018.08.008. Epub 2018 Aug 17.

PMID:
30125598
3.

Correction: Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.

Bouquegneau A, Loheac C, Aubert O, Bouatou Y, Viglietti D, Empana JP, Ulloa C, Murad MH, Legendre C, Glotz D, Jackson AM, Zeevi A, Schaub S, Taupin JL, Reed EF, Friedewald JJ, Tyan DB, Süsal C, Shapiro R, Woodle ES, Hidalgo LG, O'Leary J, Montgomery RA, Kobashigawa J, Jouven X, Jabre P, Lefaucheur C, Loupy A.

PLoS Med. 2018 Jul 27;15(7):e1002637. doi: 10.1371/journal.pmed.1002637. eCollection 2018 Jul.

4.

Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.

Bouquegneau A, Loheac C, Aubert O, Bouatou Y, Viglietti D, Empana JP, Ulloa C, Murad MH, Legendre C, Glotz D, Jackson AM, Zeevi A, Schaub S, Taupin JL, Reed EF, Friedewald JJ, Tyan DB, Süsal C, Shapiro R, Woodle ES, Hidalgo LG, O'Leary J, Montgomery RA, Kobashigawa J, Jouven X, Jabre P, Lefaucheur C, Loupy A.

PLoS Med. 2018 May 25;15(5):e1002572. doi: 10.1371/journal.pmed.1002572. eCollection 2018 May. Erratum in: PLoS Med. 2018 Jul 27;15(7):e1002637.

5.

Functional Fc gamma receptor gene polymorphisms and donor-specific antibody-triggered microcirculation inflammation.

Arnold ML, Kainz A, Hidalgo LG, Eskandary F, Kozakowski N, Wahrmann M, Haslacher H, Oberbauer R, Heilos A, Spriewald BM, Halloran PF, Böhmig GA.

Am J Transplant. 2018 Sep;18(9):2261-2273. doi: 10.1111/ajt.14710. Epub 2018 Mar 30.

6.

Single-antigen Bead Assays to Define Unacceptable Antigen Mismatches?

Böhmig GA, Hidalgo LG.

Transplantation. 2018 Jun;102(6):894-895. doi: 10.1097/TP.0000000000002128. No abstract available.

PMID:
29438141
7.

A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection.

Eskandary F, Regele H, Baumann L, Bond G, Kozakowski N, Wahrmann M, Hidalgo LG, Haslacher H, Kaltenecker CC, Aretin MB, Oberbauer R, Posch M, Staudenherz A, Handisurya A, Reeve J, Halloran PF, Böhmig GA.

J Am Soc Nephrol. 2018 Feb;29(2):591-605. doi: 10.1681/ASN.2017070818. Epub 2017 Dec 14.

8.

Review: The transcripts associated with organ allograft rejection.

Halloran PF, Venner JM, Madill-Thomsen KS, Einecke G, Parkes MD, Hidalgo LG, Famulski KS.

Am J Transplant. 2018 Apr;18(4):785-795. doi: 10.1111/ajt.14600. Epub 2017 Dec 23. Review.

9.

Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment.

Lefaucheur C, Viglietti D, Hidalgo LG, Ratner LE, Bagnasco SM, Batal I, Aubert O, Orandi BJ, Oppenheimer F, Bestard O, Rigotti P, Reisaeter AV, Kamar N, Lebranchu Y, Duong Van Huyen JP, Bruneval P, Glotz D, Legendre C, Empana JP, Jouven X, Segev DL, Montgomery RA, Zeevi A, Halloran PF, Loupy A.

J Am Soc Nephrol. 2018 Feb;29(2):620-635. doi: 10.1681/ASN.2017050589. Epub 2017 Oct 17.

10.

Mechanistic Sharing Between NK Cells in ABMR and Effector T Cells in TCMR.

Parkes MD, Halloran PF, Hidalgo LG.

Am J Transplant. 2018 Jan;18(1):63-73. doi: 10.1111/ajt.14410. Epub 2017 Aug 14.

11.

Evidence for CD16a-Mediated NK Cell Stimulation in Antibody-Mediated Kidney Transplant Rejection.

Parkes MD, Halloran PF, Hidalgo LG.

Transplantation. 2017 Apr;101(4):e102-e111. doi: 10.1097/TP.0000000000001586.

PMID:
27906829
12.

Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study.

Eskandary F, Bond G, Kozakowski N, Regele H, Marinova L, Wahrmann M, Kikić Ž, Haslacher H, Rasoul-Rockenschaub S, Kaltenecker CC, König F, Hidalgo LG, Oberbauer R, Halloran PF, Böhmig GA.

Transplantation. 2017 Mar;101(3):631-641. doi: 10.1097/TP.0000000000001195.

PMID:
27120452
13.

Multiplexed color-coded probe-based gene expression assessment for clinical molecular diagnostics in formalin-fixed paraffin-embedded human renal allograft tissue.

Adam B, Afzali B, Dominy KM, Chapman E, Gill R, Hidalgo LG, Roufosse C, Sis B, Mengel M.

Clin Transplant. 2016 Mar;30(3):295-305. doi: 10.1111/ctr.12689. Epub 2016 Feb 3.

PMID:
26729350
14.

The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors.

Venner JM, Hidalgo LG, Famulski KS, Chang J, Halloran PF.

Am J Transplant. 2015 May;15(5):1336-48. doi: 10.1111/ajt.13115. Epub 2015 Mar 17.

15.

Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.

Halloran PF, Chang J, Famulski K, Hidalgo LG, Salazar ID, Merino Lopez M, Matas A, Picton M, de Freitas D, Bromberg J, Serón D, Sellarés J, Einecke G, Reeve J.

J Am Soc Nephrol. 2015 Jul;26(7):1711-20. doi: 10.1681/ASN.2014060588. Epub 2014 Nov 6.

16.

Inhibition of the mTORC pathway in the antiphospholipid syndrome.

Hidalgo LG.

N Engl J Med. 2014 Oct 16;371(16):1554. doi: 10.1056/NEJMc1410247. No abstract available.

PMID:
25317880
17.

Molecular landscape of T cell-mediated rejection in human kidney transplants: prominence of CTLA4 and PD ligands.

Venner JM, Famulski KS, Badr D, Hidalgo LG, Chang J, Halloran PF.

Am J Transplant. 2014 Nov;14(11):2565-76. doi: 10.1111/ajt.12946. Epub 2014 Sep 12.

18.

Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection.

Loupy A, Lefaucheur C, Vernerey D, Chang J, Hidalgo LG, Beuscart T, Verine J, Aubert O, Dubleumortier S, Duong van Huyen JP, Jouven X, Glotz D, Legendre C, Halloran PF.

J Am Soc Nephrol. 2014 Oct;25(10):2267-77. doi: 10.1681/ASN.2013111149. Epub 2014 Apr 3.

19.

Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies.

Halloran PF, Reeve JP, Pereira AB, Hidalgo LG, Famulski KS.

Kidney Int. 2014 Feb;85(2):258-64. doi: 10.1038/ki.2013.300. Epub 2013 Aug 21. Review.

20.

Molecular diagnosis of antibody-mediated rejection in human kidney transplants.

Sellarés J, Reeve J, Loupy A, Mengel M, Sis B, Skene A, de Freitas DG, Kreepala C, Hidalgo LG, Famulski KS, Halloran PF.

Am J Transplant. 2013 Apr;13(4):971-983. doi: 10.1111/ajt.12150. Epub 2013 Feb 15.

21.

An analysis of regulatory T-cell and Th-17 cell dynamics during cytomegalovirus replication in solid organ transplant recipients.

Egli A, Silva M Jr, O'Shea D, Wilson LE, Baluch A, Lisboa LF, Hidalgo LG, Kumar D, Humar A.

PLoS One. 2012;7(11):e43937. doi: 10.1371/journal.pone.0043937. Epub 2012 Oct 11.

22.

Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies.

Hidalgo LG, Sellares J, Sis B, Mengel M, Chang J, Halloran PF.

Am J Transplant. 2012 May;12(5):1180-91. doi: 10.1111/j.1600-6143.2011.03970.x. Epub 2012 Mar 5.

23.

Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence.

Sellarés J, de Freitas DG, Mengel M, Reeve J, Einecke G, Sis B, Hidalgo LG, Famulski K, Matas A, Halloran PF.

Am J Transplant. 2012 Feb;12(2):388-99. doi: 10.1111/j.1600-6143.2011.03840.x. Epub 2011 Nov 14.

24.

The nature of biopsies with "borderline rejection" and prospects for eliminating this category.

de Freitas DG, Sellarés J, Mengel M, Chang J, Hidalgo LG, Famulski KS, Sis B, Einecke G, Halloran PF.

Am J Transplant. 2012 Jan;12(1):191-201. doi: 10.1111/j.1600-6143.2011.03784.x. Epub 2011 Oct 12.

25.

Inflammation lesions in kidney transplant biopsies: association with survival is due to the underlying diseases.

Sellarés J, de Freitas DG, Mengel M, Sis B, Hidalgo LG, Matas AJ, Kaplan B, Halloran PF.

Am J Transplant. 2011 Mar;11(3):489-99. doi: 10.1111/j.1600-6143.2010.03415.x.

26.

An integrated view of molecular changes, histopathology and outcomes in kidney transplants.

Halloran PF, de Freitas DG, Einecke G, Famulski KS, Hidalgo LG, MengeL M, Reeve J, Sellares J, Sis B.

Am J Transplant. 2010 Oct;10(10):2223-30.

PMID:
20931696
27.

The molecular phenotype of kidney transplants.

Halloran PF, de Freitas DG, Einecke G, Famulski KS, Hidalgo LG, Mengel M, Reeve J, Sellares J, Sis B.

Am J Transplant. 2010 Oct;10(10):2215-22.

PMID:
20931695
28.

The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables.

Mengel M, Sis B, Kim D, Chang J, Famulski KS, Hidalgo LG, Einecke G, de Freitas DG, Tymchak W, Burton J, Halloran PF.

Am J Transplant. 2010 Sep;10(9):2105-15. doi: 10.1111/j.1600-6143.2010.03182.x.

29.

NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection.

Hidalgo LG, Sis B, Sellares J, Campbell PM, Mengel M, Einecke G, Chang J, Halloran PF.

Am J Transplant. 2010 Aug;10(8):1812-22. doi: 10.1111/j.1600-6143.2010.03201.x.

30.

Defining the canonical form of T-cell-mediated rejection in human kidney transplants.

Famulski KS, Einecke G, Sis B, Mengel M, Hidalgo LG, Kaplan B, Halloran PF.

Am J Transplant. 2010 Apr;10(4):810-20. doi: 10.1111/j.1600-6143.2009.03007.x. Epub 2010 Feb 3.

31.

Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring.

Sis B, Einecke G, Chang J, Hidalgo LG, Mengel M, Kaplan B, Halloran PF.

Am J Transplant. 2010 Feb;10(2):421-30. doi: 10.1111/j.1600-6143.2009.02938.x. Epub 2010 Jan 6.

32.

De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure.

Hidalgo LG, Campbell PM, Sis B, Einecke G, Mengel M, Chang J, Sellares J, Reeve J, Halloran PF.

Am J Transplant. 2009 Nov;9(11):2532-41. doi: 10.1111/j.1600-6143.2009.02800.x.

33.

Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure.

Einecke G, Sis B, Reeve J, Mengel M, Campbell PM, Hidalgo LG, Kaplan B, Halloran PF.

Am J Transplant. 2009 Nov;9(11):2520-31. doi: 10.1111/j.1600-6143.2009.02799.x.

34.

Molecular correlates of renal function in kidney transplant biopsies.

Bunnag S, Einecke G, Reeve J, Jhangri GS, Mueller TF, Sis B, Hidalgo LG, Mengel M, Kayser D, Kaplan B, Halloran PF.

J Am Soc Nephrol. 2009 May;20(5):1149-60. doi: 10.1681/ASN.2008080863. Epub 2009 Apr 23.

35.

Comparing microarray versus RT-PCR assessment of renal allograft biopsies: similar performance despite different dynamic ranges.

Allanach K, Mengel M, Einecke G, Sis B, Hidalgo LG, Mueller T, Halloran PF.

Am J Transplant. 2008 May;8(5):1006-15. doi: 10.1111/j.1600-6143.2008.02199.x.

36.

The transcriptome of human cytotoxic T cells: measuring the burden of CTL-associated transcripts in human kidney transplants.

Hidalgo LG, Einecke G, Allanach K, Mengel M, Sis B, Mueller TF, Halloran PF.

Am J Transplant. 2008 Mar;8(3):637-46. doi: 10.1111/j.1600-6143.2007.02129.x.

37.

The transcriptome of human cytotoxic T cells: similarities and disparities among allostimulated CD4(+) CTL, CD8(+) CTL and NK cells.

Hidalgo LG, Einecke G, Allanach K, Halloran PF.

Am J Transplant. 2008 Mar;8(3):627-36. doi: 10.1111/j.1600-6143.2007.02128.x.

38.

Tubulitis and epithelial cell alterations in mouse kidney transplant rejection are independent of CD103, perforin or granzymes A/B.

Einecke G, Fairhead T, Hidalgo LG, Sis B, Turner P, Zhu LF, Bleackley RC, Hadley GA, Famulski KS, Halloran PF.

Am J Transplant. 2006 Sep;6(9):2109-20. Epub 2006 Jul 26.

39.

Changes in the transcriptome in allograft rejection: IFN-gamma-induced transcripts in mouse kidney allografts.

Famulski KS, Einecke G, Reeve J, Ramassar V, Allanach K, Mueller T, Hidalgo LG, Zhu LF, Halloran PF.

Am J Transplant. 2006 Jun;6(6):1342-54.

40.
41.

Heterogeneity in the evolution and mechanisms of the lesions of kidney allograft rejection in mice.

Jabs WJ, Sedlmeyer A, Ramassar V, Hidalgo LG, Urmson J, Afrouzian M, Zhu LF, Halloran PF.

Am J Transplant. 2003 Dec;3(12):1501-9.

42.

The role of B cells and alloantibody in the host response to human organ allografts.

Vongwiwatana A, Tasanarong A, Hidalgo LG, Halloran PF.

Immunol Rev. 2003 Dec;196:197-218. Review.

PMID:
14617206
43.

Role of IFN-gamma in allograft rejection.

Hidalgo LG, Halloran PF.

Crit Rev Immunol. 2002;22(4):317-49. Review.

PMID:
12678431

Supplemental Content

Loading ...
Support Center